|
|
Biography |
|
|
Professor Mona K. Marei, Professor of prosthetic Dentistry. She is the founder and the head of tissue engineering science and technology/laboratories-Alexandria University, Egypt. In December 2011 she was elected to be the President of the African – Material Research Society. In 2009, she was appointed a board member of higher council of industrial technology — Ministry of scientific research, in 2008 — a board member of permanent scientific higher committee for promotion in Dentistr — yMinistry of higher education — Egypt. And 2006 as an invited visiting professor in the national specialized council for education, scientific research and technology — genetic engineering committee-presidential republic office. Professor Marei is an international advisory board member in: Africa Renaissance Institute of Science and Technology "ARIST" (http://www.arist-edu.org/)-Burkina Faso, in Technology Innovation Scientific Committee — University of Bambey-Senegal, and in "NSF's — "International Material Institute for New Functionality, in Glass-LehighUniversity/US (http://www.lehigh.edu/imi/). She served the vice-president of Tissue-Engineering Society International "TESI" (http://www.termis.org/) – for emerging countries. (2003-2005), the member-at-large for emerging countries in the Tissue Engineering and Regenerative Medicine International Society "TERMIS" (http://www.termis.org/) 2005-2008, and executive board member in African Materials Research society "A-MRS" (http://www.africamrs.org/) (2005). Professor. Mona K. Marei has served in the executive editorial board of Tissue Engineering Journals parts A, Band C (http://www.liebertpub.com/products/product.aspx?pid=315). Associate editor board of the Annals of Biomedical Engineering (http://www.editorialmanager.com/abme/), editorial board in the International Journal of Artificial Organs(http://www.artificial-organs.com/public/ijao/default.aspx), peer-reviewer in the Eastern Mediterranean Health journal (EMHJ), "WHO-EMRO" (http://www.emro.who.int/emhj.htm), and peer reviewer in Journal of Dentistry and Oral Hygiene (JDOH). Dr Marei is the principal invistigator, and team leader for a number of national and international projects and agreements in the field of biomaterials, biomedical engineering, regenerative medicine and tissue engineering. She is one of the national experts in the science and technology, reviewer in the Science and Technology Development Fund "STDF" (http://www.stdf.org.eg/), national research/Development and innovation "RDI" (http://www.rdi-eg.com/rdi/index.htm) program, US/Egypt, German/Egypt-research fund agreement (GERF), Swedish International Development Co-operation Agency "SIDA", Center of Special Studies and Programs "CSSP" (http://www.bibalex.org/baanniversary/ANWIST.html) Biblothica Alexandrina and in a number of academic/educational programs national and international. She directs the international student exchange activities in Biomedical Engineering for the emerging countries, and she supervise numerous MSc and PhD theses in the field of Dentistry, Biomaterial, Biomedical Engineering and Regenerative Medicine. Dr. Marei published numerous articles in international scientific journals and received a patent #23731 in July 2007 from Ministry of scientific research, several awards, medals and certificate of recognition. She organized a number of training courses, workshops, public awareness seminars and conferences. Dr. Marei is a member of many distinguished societies for women recognition in science and technology e.g. Arab network for women in science and technology (ANWIST). She was invited keynote and plenary speaker for numerous international conferences for the past 20 years of her career.
|
|
|
|
|
|
|
Abstract |
|
|
|
|
The Clinical and Commercial Translation of Break-Through Innovations of Regenerative Therapy |
|
|
|
|
|
After decades of progress, regenerative therapy has matured, integrated, and diversified into entirely new areas that are undergoing a pivotal shift towards translation. While regenerative therapy is considered the most exciting science in the 20th century, it continues to emerge at the boundaries of its disciplines through increasingly effective interactions between clinicians and the commercial sectors. The objectives remain intact; to repair and replacement of the injured, diseased or lost tissues and organs, however, in recent years, the field has been extended to an equally important application of engineered tissues for drug testing, disease modeling, and precision medicine. Clearly, both the regenerative medicine application and the in-vitro tissue platforms have vast potential for understanding and treating human disease. Although the commercial development of regenerative therapy is still at the proof-of-concept stage due to technology risks, changing policies, changing markets, and limitations of scientific understanding in regulatory decision-making, the sector is highly dynamic with a number of explored therapeutic approaches, developed by using a large diversity of business models, both proposed by the experience and pitfalls. Innovation is the prime motor of economic growth in general, and biotechnological innovation, in particular, has driven outstanding economic benefits in countries and regional clusters that nurtured its development. Within the last few years, progress in methodology and understanding the process of diseases have produced market technologies that dramatically reduce the cost, the time, and the complexity to fabricate three dimensional biological structures and are considered the precursors to tomorrow's human tissue spare parts. We are now at the beginning of the golden age of ‘Bio-economy’. This presentation will highlight some of the major advances that have shown successful clinical translation in the field and presenting cutting edge technology development, and commercialization strategies. |
|
|
|
|